Propofol Injection, Emulsion
Product Images NDC 0409-0010

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Propofol (NDC 0409-0010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Propofol 01)

Chemical structure of propofol showing its molecular arrangement with a phenol ring and two isopropyl groups, representing the active ingredient in the PROPOFOL 10 mg/mL injection emulsion by Hospira, Inc.*

FDA Label Image

Graph (Propofol 02)

A line graph showing plasma propofol concentration (mcg/mL) over time (minutes) after end of infusion. It compares recovery profiles after 1 hour, 10 hour, and 10 day infusions, indicating how plasma levels decline and approach the awakening concentration threshold.*

FDA Label Image

Hospira Logo (Propofol 03)

FDA Label Image

Principal Display Panel (20 mL Vial Label)

Label for PROPOFOL Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Hospira, Inc. Includes warnings about benzyl alcohol content, microbial growth inhibition within 12 hours after opening, and uses aseptic technique. Lists ingredients per mL and storage instructions. The label also states the product is Rx only and provides distributor information.*

FDA Label Image

Principal Display Panel (20 mL Vial Carton)

Packaging label for PROPOFOL Injectable Emulsion, USP 200 mg/20 mL (10 mg/mL) distributed by Hospira, Inc. The label indicates the product contains benzyl alcohol and is for intravenous administration. It comes in a box of 5 x 20 mL vials for single patient use. The label includes warnings about microbial growth inhibition by benzyl alcohol and instructions to discard within 12 hours of opening, emphasizing strict aseptic technique.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label for PROPOFOL Injectable Emulsion USP 500 mg/50 mL (10 mg/mL) by Hospira, Inc. The label indicates it contains benzyl alcohol and is for intravenous administration. It instructs to shake well before using and notes single patient use only. The NDC is 0409-4699-53, with storage and dosage instructions partially visible.*

FDA Label Image

Principal Display Panel (50 mL Vial Tray)

Packaging label for PROPOFOL Injectable Emulsion, USP 500 mg/50 mL (10 mg/mL) injection, emulsion for intravenous administration. The box contains 20 x 50 mL vials. The label notes that it contains benzyl alcohol and is distributed by Hospira, Inc.*

FDA Label Image

Propofol 08

PROPOFOL 10 mg/mL injectable emulsion for intravenous use in a 20 mL vial. The label indicates it contains 200 mg per 20 mL, with benzyl alcohol as a preservative. Instructions include shaking well before use, noting microbial inhibition up to 12 hours, and disposal recommendations. Distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Propofol 09

PROPOFOL Injectable Emulsion USP 200 mg/20 mL (10 mg/mL) injection for intravenous administration. The label indicates the product contains benzyl alcohol and is supplied in 25 x 20 mL vials. The manufacturer is Hospira, Inc. Storage instructions specify storing at 20° to 25°C, not freezing, and shaking well before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.